Collplant Price To Sales Ratio vs Inventory Turnover Analysis

CLGN Stock

USD 4.48 0.23 5.41%

Collplant Biotechnologies financial indicator trend analysis is way more than just evaluating Collplant Biotechnologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Collplant Biotechnologies is a good investment. Please check the relationship between Collplant Biotechnologies Price To Sales Ratio and its Inventory Turnover accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

Price To Sales Ratio vs Inventory Turnover

Price To Sales Ratio vs Inventory Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Collplant Biotechnologies Price To Sales Ratio account and Inventory Turnover. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Collplant Biotechnologies' Price To Sales Ratio and Inventory Turnover is -0.24. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Inventory Turnover in the same time period over historical financial statements of Collplant Biotechnologies, assuming nothing else is changed. The correlation between historical values of Collplant Biotechnologies' Price To Sales Ratio and Inventory Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Collplant Biotechnologies are associated (or correlated) with its Inventory Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory Turnover has no effect on the direction of Price To Sales Ratio i.e., Collplant Biotechnologies' Price To Sales Ratio and Inventory Turnover go up and down completely randomly.

Correlation Coefficient

-0.24

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Collplant Biotechnologies stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Collplant Biotechnologies sales, a figure that is much harder to manipulate than other Collplant Biotechnologies multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most indicators from Collplant Biotechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Collplant Biotechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.As of the 29th of November 2024, Enterprise Value is likely to grow to about 59.3 M, while Selling General Administrative is likely to drop about 3.8 M.

	2021	2023	2024 (projected)
Interest Expense	37K	10K	9.5K
Depreciation And Amortization	773K	1.1M	874.1K

Interest Expense Depreciation And Amortization

Collplant Biotechnologies fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Intangible Assets	Common Stock	Net Tangible Assets	Property Plant Equipment	Non Current Liabilities Total
Common Stock Shares Outstanding		0.84	0.74	0.82	0.87	0.86	-0.73	-0.95	0.61	0.81	0.87	-0.36	-0.23	0.87	-0.36	0.96	0.61	0.93	0.76	0.94	0.81	-0.74	0.93	0.92	0.81	0.66
Total Assets	0.84		0.53	0.63	0.95	0.77	-0.67	-0.71	0.51	0.71	0.79	-0.05	-0.29	0.95	-0.52	0.72	0.58	0.91	0.58	0.74	0.99	-0.48	0.9	0.83	0.68	0.47
Other Current Liab	0.74	0.53		0.91	0.43	0.89	-0.37	-0.85	0.46	0.48	0.88	-0.34	-0.23	0.43	-0.12	0.87	0.33	0.79	0.85	0.76	0.45	-0.92	0.81	0.53	0.82	0.7
Total Current Liabilities	0.82	0.63	0.91		0.52	0.95	-0.37	-0.88	0.64	0.48	0.94	-0.12	-0.08	0.52	-0.17	0.9	0.45	0.84	0.93	0.75	0.55	-0.96	0.85	0.57	0.91	0.74
Total Stockholder Equity	0.87	0.95	0.43	0.52		0.67	-0.78	-0.71	0.46	0.82	0.7	-0.24	-0.34	1.0	-0.56	0.72	0.52	0.84	0.46	0.81	0.95	-0.38	0.82	0.93	0.58	0.39
Property Plant And Equipment Net	0.86	0.77	0.89	0.95	0.67		-0.49	-0.89	0.58	0.59	1.0	-0.14	-0.21	0.67	-0.41	0.9	0.47	0.92	0.86	0.81	0.7	-0.91	0.93	0.68	0.92	0.69
Net Debt	-0.73	-0.67	-0.37	-0.37	-0.78	-0.49		0.69	-0.35	-0.98	-0.51	0.56	0.51	-0.77	0.55	-0.62	-0.4	-0.69	-0.27	-0.68	-0.67	0.23	-0.67	-0.88	-0.41	-0.2
Retained Earnings	-0.95	-0.71	-0.85	-0.88	-0.71	-0.89	0.69		-0.64	-0.79	-0.89	0.44	0.24	-0.71	0.26	-0.98	-0.58	-0.91	-0.84	-0.91	-0.65	0.83	-0.91	-0.84	-0.85	-0.74
Accounts Payable	0.61	0.51	0.46	0.64	0.46	0.58	-0.35	-0.64		0.41	0.58	0.0	0.37	0.47	0.07	0.57	0.44	0.63	0.61	0.52	0.47	-0.49	0.61	0.53	0.77	0.45
Cash	0.81	0.71	0.48	0.48	0.82	0.59	-0.98	-0.79	0.41		0.61	-0.58	-0.51	0.81	-0.51	0.73	0.47	0.76	0.41	0.78	0.7	-0.36	0.74	0.92	0.5	0.36
Non Current Assets Total	0.87	0.79	0.88	0.94	0.7	1.0	-0.51	-0.89	0.58	0.61		-0.13	-0.21	0.69	-0.43	0.91	0.48	0.93	0.85	0.81	0.72	-0.9	0.94	0.7	0.92	0.68
Non Currrent Assets Other	-0.36	-0.05	-0.34	-0.12	-0.24	-0.14	0.56	0.44	0.0	-0.58	-0.13		0.34	-0.23	0.12	-0.4	0.08	-0.21	-0.07	-0.58	-0.04	0.15	-0.19	-0.51	-0.13	-0.12
Other Assets	-0.23	-0.29	-0.23	-0.08	-0.34	-0.21	0.51	0.24	0.37	-0.51	-0.21	0.34		-0.34	0.41	-0.27	0.03	-0.25	-0.1	-0.27	-0.29	0.07	-0.25	-0.27	0.14	-0.18
Cash And Short Term Investments	0.87	0.95	0.43	0.52	1.0	0.67	-0.77	-0.71	0.47	0.81	0.69	-0.23	-0.34		-0.52	0.72	0.55	0.84	0.48	0.81	0.96	-0.38	0.82	0.92	0.57	0.44
Net Receivables	-0.36	-0.52	-0.12	-0.17	-0.56	-0.41	0.55	0.26	0.07	-0.51	-0.43	0.12	0.41	-0.52		-0.25	-0.04	-0.4	0.03	-0.36	-0.51	0.16	-0.4	-0.48	-0.28	0.14
Common Stock Total Equity	0.96	0.72	0.87	0.9	0.72	0.9	-0.62	-0.98	0.57	0.73	0.91	-0.4	-0.27	0.72	-0.25		0.56	0.89	0.86	0.93	0.66	-0.86	0.9	0.81	0.82	0.77
Other Current Assets	0.61	0.58	0.33	0.45	0.52	0.47	-0.4	-0.58	0.44	0.47	0.48	0.08	0.03	0.55	-0.04	0.56		0.63	0.6	0.39	0.58	-0.38	0.63	0.54	0.45	0.66
Other Stockholder Equity	0.93	0.91	0.79	0.84	0.84	0.92	-0.69	-0.91	0.63	0.76	0.93	-0.21	-0.25	0.84	-0.4	0.89	0.63		0.79	0.83	0.87	-0.73	1.0	0.85	0.85	0.65
Total Liab	0.76	0.58	0.85	0.93	0.46	0.86	-0.27	-0.84	0.61	0.41	0.85	-0.07	-0.1	0.48	0.03	0.86	0.6	0.79		0.68	0.51	-0.9	0.8	0.5	0.79	0.93
Property Plant And Equipment Gross	0.94	0.74	0.76	0.75	0.81	0.81	-0.68	-0.91	0.52	0.78	0.81	-0.58	-0.27	0.81	-0.36	0.93	0.39	0.83	0.68		0.7	-0.71	0.83	0.9	0.76	0.61
Total Current Assets	0.81	0.99	0.45	0.55	0.95	0.7	-0.67	-0.65	0.47	0.7	0.72	-0.04	-0.29	0.96	-0.51	0.66	0.58	0.87	0.51	0.7		-0.39	0.86	0.82	0.61	0.42
Intangible Assets	-0.74	-0.48	-0.92	-0.96	-0.38	-0.91	0.23	0.83	-0.49	-0.36	-0.9	0.15	0.07	-0.38	0.16	-0.86	-0.38	-0.73	-0.9	-0.71	-0.39		-0.76	-0.46	-0.86	-0.74
Common Stock	0.93	0.9	0.81	0.85	0.82	0.93	-0.67	-0.91	0.61	0.74	0.94	-0.19	-0.25	0.82	-0.4	0.9	0.63	1.0	0.8	0.83	0.86	-0.76		0.83	0.86	0.65
Net Tangible Assets	0.92	0.83	0.53	0.57	0.93	0.68	-0.88	-0.84	0.53	0.92	0.7	-0.51	-0.27	0.92	-0.48	0.81	0.54	0.85	0.5	0.9	0.82	-0.46	0.83		0.66	0.43
Property Plant Equipment	0.81	0.68	0.82	0.91	0.58	0.92	-0.41	-0.85	0.77	0.5	0.92	-0.13	0.14	0.57	-0.28	0.82	0.45	0.85	0.79	0.76	0.61	-0.86	0.86	0.66		0.57
Non Current Liabilities Total	0.66	0.47	0.7	0.74	0.39	0.69	-0.2	-0.74	0.45	0.36	0.68	-0.12	-0.18	0.44	0.14	0.77	0.66	0.65	0.93	0.61	0.42	-0.74	0.65	0.43	0.57

Click cells to compare fundamentals

Collplant Biotechnologies Account Relationship Matchups

Collplant Biotechnologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	5.0M	6.9M	12.0M	11.0M	11.4M	12.0M
Total Assets	10.8M	10.8M	51.2M	37.8M	34.1M	18.2M
Other Current Liab	1.2M	1.5M	910K	914K	1.6M	876.2K
Total Current Liabilities	3.5M	3.4M	3.0M	3.1M	3.3M	2.4M
Total Stockholder Equity	4.1M	4.5M	45.1M	32.3M	28.3M	29.8M
Property Plant And Equipment Net	5.5M	4.9M	5.7M	5.7M	5.9M	3.3M
Net Debt	(173K)	55K	(9.5M)	(26.7M)	(23.5M)	(22.3M)
Retained Earnings	(67.3M)	(73.0M)	(72.8M)	(89.7M)	(96.7M)	(91.9M)
Accounts Payable	833K	798K	1.0M	1.1M	980K	918.1K
Cash	3.8M	3.3M	13.1M	29.7M	26.7M	28.0M
Non Current Assets Total	5.7M	5.2M	6.1M	6.1M	6.1M	3.8M
Non Currrent Assets Other	168K	181K	213K	188K	57K	54.2K
Other Assets	168K	181K	213K	1.0	0.9	0.86
Cash And Short Term Investments	3.8M	3.3M	43.3M	29.7M	26.7M	28.0M
Net Receivables	265K	830K	270K	9K	393K	433.1K
Common Stock Total Equity	1.4M	1.5M	2.4M	2.9M	3.4M	3.5M
Liabilities And Stockholders Equity	10.8M	10.8M	51.2M	37.8M	34.1M	18.2M
Other Current Assets	96K	251K	437K	566K	241K	283.1K
Other Stockholder Equity	69.9M	75.5M	114.2M	118.1M	121.1M	76.5M
Total Liab	6.7M	6.4M	6.1M	5.5M	5.8M	4.5M
Property Plant And Equipment Gross	5.5M	4.9M	9.7M	5.7M	11.9M	12.5M
Total Current Assets	5.0M	5.7M	45.1M	31.7M	28.0M	14.4M
Common Stock	2.4M	2.9M	4.7M	4.9M	5.0M	2.6M
Other Liab	404.9K	1.1M	68K	28K	25.2K	23.9K
Net Tangible Assets	5.4M	4.1M	4.4M	44.9M	51.6M	54.2M
Inventory	888K	1.3M	1.1M	1.4M	714K	716.5K
Short Term Debt	479K	880K	1.0M	1.1M	624K	451.2K
Property Plant Equipment	1.4M	5.5M	4.9M	5.7M	6.5M	3.5M
Non Current Liabilities Total	3.2M	3.0M	3.1M	2.4M	2.5M	2.9M
Short Long Term Debt Total	3.6M	3.4M	3.6M	2.9M	3.2M	3.2M
Net Invested Capital	4.1M	4.5M	45.1M	32.3M	28.3M	19.7M
Net Working Capital	1.6M	2.3M	42.1M	28.6M	24.8M	17.2M
Capital Stock	2.4M	2.9M	4.7M	4.9M	5.0M	3.9M

Pair Trading with Collplant Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collplant Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving together with Collplant Stock

0.85

ELAN

Elanco Animal Health Potential Growth

Pair Corr

Moving against Collplant Stock

0.88	EWTX	Edgewise Therapeutics	Pair Corr
0.85	GILD	Gilead Sciences	Pair Corr
0.79	BHC	Bausch Health Companies	Pair Corr
0.76	GANX	Gain Therapeutics	Pair Corr
0.68	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr

The ability to find closely correlated positions to Collplant Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collplant Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collplant Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collplant Biotechnologies to buy it.

The correlation of Collplant Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collplant Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collplant Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Collplant Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Collplant Biotechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Collplant Biotechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Collplant Biotechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Collplant Biotechnologies Stock:

How To Invest In Collplant

Details

Is Collplant Stock a good investment?

Details

What is Collplant Biotechnologies' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.53)

Revenue Per Share

0.06

Quarterly Revenue Growth

(0.98)

Return On Assets

(0.34)

Return On Equity

(0.62)

The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Collplant Price To Sales Ratio vs Inventory Turnover Analysis

Price To Sales Ratio vs Inventory Turnover

Price To Sales Ratio vs Inventory Turnover Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Inventory Turnover

Collplant Biotechnologies fundamental ratios Correlations

Collplant Biotechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Collplant Biotechnologies fundamental ratios Accounts

Pair Trading with Collplant Biotechnologies

Moving together with Collplant Stock

Moving against Collplant Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Common Stock	+ 1.0	Other Stockholder Equity
Total Current Assets	+ 0.99	Total Assets
Common Stock Total Equity	+ 0.96	Common Stock Shares Outstanding
Total Current Assets	+ 0.96	Cash And Short Term Investments

Common Stock Total Equity	- 0.98	Retained Earnings
Cash	- 0.98	Net Debt
Intangible Assets	- 0.96	Total Current Liabilities
Retained Earnings	- 0.95	Common Stock Shares Outstanding
Intangible Assets	- 0.92	Other Current Liab
Common Stock	- 0.91	Retained Earnings